Table 2 Comparison of anti-MDA5 and anti-Ro52 antibody levels between patients with MDA5+DM in the survival and non-survival groups
Non-survival group (N = 32) | Survival group (N = 94) | P-value | |
|---|---|---|---|
MDA5, no. (%) | |||
Weak (1+) | 2 (6.3) | 11 (11.7) | 0.590 |
Moderate (2+) | 3 (9.4) | 12 (12.8) | 0.845 |
Strong (3+) | 27 (84.4) | 71 (75.5) | 0.299 |
Ro52, no. (%) | |||
Negative | 6 (18.8) | 44 (46.8) | 0.005 |
Weak (1+) | 1 (3.1) | 11 (11.7) | 0.281 |
Moderate (2+) | 4 (12.5) | 11 (11.7) | 1.000 |
Strong (3+) | 21 (65.6) | 28 (29.8) | < 0.001 |